Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Burden of lung cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030
Yuan Fang, Zhen Li, Hui Chen, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 7, pp. 3209-3218
Closed Access | Times Cited: 18

Showing 18 citing articles:

Burden of drug use disorders in the United States from 1990 to 2021 and its projection until 2035: results from the GBD study
Tongchao Zhang, Lin Sun, Xiaolin Yin, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 15
Next-generation EGFR tyrosine kinase inhibitors to overcome C797S mutation in non-small cell lung cancer (2019–2024)
Debasis Das, Lingzhi Xie, Hong Jian
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 11
Epidemiological Trends of Kidney Cancer Along with Attributable Risk Factors in China from 1990 to 2019 and Its Projections Until 2030: An Analysis of the Global Burden of Disease Study 2019
Qianqian Xu, Tingxiao Zhang, Tong Xia, et al.
Clinical Epidemiology (2023) Vol. Volume 15, pp. 421-433
Open Access | Times Cited: 18
Trends in Cancer Incidence and Potential Associated Factors in China
Mandi Li, Meijing Hu, Lin Jiang, et al.
JAMA Network Open (2024) Vol. 7, Iss. 10, pp. e2440381-e2440381
Open Access | Times Cited: 5
Cost-effectiveness analysis of gumarontinib versus savolitinib for the treatment of advanced or metastatic NSCLC with MET exon 14 skipping mutations in China using partitioned survival model
Gang Fang, Zhipeng Pi, Yu An, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Trends and projection of burden on lung cancer and risk factors in China from 1990 to 2060
Baozhen He, Xingyu Zhao, Yang Pu, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 22, pp. 1688-1704
Open Access | Times Cited: 4
Screening for lung cancer using thin‐slice low‐dose computed tomography in southwestern China: a population‐based real‐world study
Jiaxuan Wu, Ruicen Li, Huohuo Zhang, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 19, pp. 1522-1532
Open Access | Times Cited: 3
Disease Burden and Prediction Analysis of Tracheal, Bronchus, and Lung Cancer Attributable to Residential Radon, Solid Fuels, and Particulate Matter Pollution Under Different Sociodemographic Transitions From 1990 to 2030
Yan Liu, Haoyu Wen, Jianjun Bai, et al.
CHEST Journal (2023) Vol. 165, Iss. 2, pp. 446-460
Closed Access | Times Cited: 7
Risk-adapted starting age of personalized lung cancer screening: a population-based, prospective cohort study in China
Chenran Wang, Xuesi Dong, Fengwei Tan, et al.
CHEST Journal (2024) Vol. 165, Iss. 6, pp. 1538-1554
Closed Access | Times Cited: 2
Combined detection of serum IL-6 and CEA contributes to the diagnosis of lung adenocarcinoma in situ
Jing Pan, Wanzhen Zhuang, Yu Xia, et al.
PeerJ (2024) Vol. 12, pp. e17141-e17141
Open Access | Times Cited: 2
Burden of malignant mesothelioma in China during 1990–2019 and the projections through 2029
Qiulin Huang, Youli Chen, Liyou Lian, et al.
Journal of the National Cancer Center (2024) Vol. 4, Iss. 3, pp. 214-222
Open Access | Times Cited: 1
Effect of preoperative inspiratory muscle training combined with preoperative education on postoperative pulmonary complications in high-risk patients with lung cancer: protocol for a randomised controlled trial
Ting Lu, Xichen Wang, Zhengxuan Shi, et al.
BMJ Open (2024) Vol. 14, Iss. 11, pp. e084072-e084072
Open Access | Times Cited: 1
Identification of the Core Nutrition Impact Symptoms Cluster in Patients with Lung Cancer During Chemotherapy: A Symptom Network Analysis
Dandan Zheng, Ting Jin, Dan Li, et al.
Seminars in Oncology Nursing (2024), pp. 151794-151794
Open Access | Times Cited: 1
A Synthesizing Semantic Characteristics Lung Nodules Classification Method Based on 3D Convolutional Neural Network
Yanan Dong, Xiaoqin Li, Yang Yang, et al.
Bioengineering (2023) Vol. 10, Iss. 11, pp. 1245-1245
Open Access | Times Cited: 3
Global estimates of rehabilitation needs and disease burden in tracheal, bronchus, and lung cancer from 1990 to 2019 and projections to 2045 based on the global burden of disease study 2019
Xigui Lai, Conghui Li, Yao Yang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Effect of preoperative natural killer cell on postoperative pulmonary complications in patients of lung cancer − A single-center retrospective cohort study
Qinyue Yuan, Shichao Wang, Haipeng Zhu, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112564-112564
Closed Access
Screening for lung cancer using thin-slice low-dose computed tomography in a Chinese physical examination population: a population-based real-world study
Jiaxuan Wu, Ruicen Li, Huohuo Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Incidence and mortality of lung cancer in 2018 and the temporal trends from 2010 to 2018 in Henan province, China: a population-based registry study
Yin Liu, Qiong Chen, Lanwei Guo, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 18, pp. 1005-1005
Open Access | Times Cited: 1
Page 1

Scroll to top